Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
The Clinical Picture

Posterior reversible encephalopathy syndrome

Balaj Rai, MD, Robert M. Black, MD and Vinit Gilvaz, MD
Cleveland Clinic Journal of Medicine March 2020, 87 (3) 131-132; DOI: https://doi.org/10.3949/ccjm.87a.18139
Balaj Rai
The Christ Hospital, Cincinnati, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Robert M. Black
Chief of Nephrology, Department of Medicine, Saint Vincent Hospital, Worcester, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vinit Gilvaz
Saint Vincent Hospital, Worcester, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

A 70-year-old man with dyslipidemia and new-onset hypertension presented to the emergency room with nausea, fatigue, and confusion. His blood pressure was 148/87 mm Hg. Computed tomography (CT) without contrast was performed as part of the evaluation of his acute-onset altered mental status, and showed no acute intracranial abnormalities (Figure 1).

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

On presentation, noncontrast computed tomography (CT) was normal.

The patient was admitted to the hospital for observation. His blood pressure remained poorly controlled. On hospital day 4, he developed severe right occipital headache and blurred vision, and his blood pressure was noted to be 209/93 mm Hg. Repeat noncontrast CT showed hypodensities (vasogenic edema) in both occipital lobes (Figure 2), which, along with his symptoms, raised the suspicion of posterior reversible encephalopathy syndrome. The findings were confirmed on magnetic resonance imaging (MRI) (Figure 3).

Figure 2
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2

On hospital day 4, repeat CT imaging showed areas of hypodensity in both occipital lobes (arrows), indicating vasogenic edema.

Figure 3
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3

Magnetic resonance imaging on hospital day 4 noted hyperintensities on T2 (top) and diffusion-weighted images (bottom), confirming findings on tomography.

The patient’s symptoms were better the next day, after his blood pressure had been brought under control with intravenous hydralazine. On day 10, repeat noncontrast CT showed the vasogenic edema had nearly resolved (Figure 4), and his visual complaints had completely resolved.

Figure 4
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4

On hospital day 10, the vasogenic edema had nearly resolved.

EPIDEMIOLOGY AND PATHOPHYSIOLOGY

Posterior reversible encephalopathy syndrome is a rare condition most often seen in hypertensive emergencies but also in sepsis, preeclampsia, eclampsia, and with the use of cytotoxic medications such as cyclosporine and tacrolimus.1 It is thought to occur secondary to derangement in cerebral autoregulation with subsequent hyperperfusion, resulting in endothelial damage and vasogenic edema.2 In a series of 70 patients admitted to the intensive care unit, 11 (16%) died within 90 days, but 33 (47%) had a good recovery.3

CLINICAL PRESENTATION AND TREATMENT

The diagnosis is often missed. The clinical presentation typically consists of headaches, visual disturbances, seizures, and altered mental status.4 Features most commonly observed on CT or MRI are edema or swelling in the parieto-occipital white matter. On MRI, the syndrome usually manifests as a T2 hyperintensity with normal diffusion-weighted imaging.

Clinical symptoms and radiologic findings can improve rapidly with management of blood pressure. Late diagnosis or inadequate therapy may contribute to long-term sequelae such as permanent neurologic disability or death from progressive cerebral edema and intracranial hemorrhage.5

TAKE-HOME POINTS

  • Posterior reversible encephalopathy syndrome is usually reversible, and many patients recover fully.

  • Clinical and radiologic manifestations resolve rapidly with blood pressure management.

  • Copyright © 2020 The Cleveland Clinic Foundation. All Rights Reserved.

REFERENCES

    1. Fugate JE,
    2. Claassen DO,
    3. Cloft HJ,
    4. Kallmes DF,
    5. Kozak OS,
    6. Rabinstein AA
    . Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 2010; 85(5):427–432. doi:10.4065/mcp.2009.0590
    1. Bartynski WS
    . Posterior reversible encephalopathy syndrome, Part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 2008; 29(6):1043–1049. doi:10.3174/ajnr.A0929
    1. Legriel S,
    2. Schraub O,
    3. Azoulay E, et al; Critically III Posterior Reversible Encephalopathy Syndrome Study Group (CYPRESS)
    . Determinants of recovery from severe posterior reversible encephalopathy syndrome. PLoS One 2012; 7(9):e44534. doi:10.1371/journal.pone.0044534
    1. Hinchey J,
    2. Chaves C,
    3. Appignani B, et al
    . A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334(8):494–500. doi:10.1056/NEJM199602223340803
    1. Covarrubias DJ,
    2. Luetmer PH,
    3. Campeau NG
    . Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 2002; 23(6):1038–1048. pmid:12063238

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire